Saturday, December 20, 2025

Latest

Singapore-Based A SPAC I Acquisition Prices US$60 Million IPO

Special purpose acquisition company A SPAC I Acquisition Corp. started trading on the Nasdaq Capital Market today. The firm aims to raise US$60.0 million in its initial public offering.

The offering consisted of 6.0 million company units at US$10.00 per unit. Each unit contains one Class A common share, three-fourths of a redeemable warrant, and one-tenth of a right. Each whole warrant is exercisable for one common share at US$11.50 per share while each whole right equates to one common share upon business combination. The shares, warrants, and rights, once trading separately, will be trading under “ASCA”, “ASCAW”, and “ASCAR”, respectively.

Chardan acts as the sole bookrunner for the said offering. The underwriters were granted a 45-day overallotment option to purchase additional 0.9 million units at the same IPO price.

The offering is expected to close on February 17, 2022, subject to customary closing conditions.

The Singapore-based blank check firm intends to focus on completing a business combination in the technology, media, and telecom (TMT) sector.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Soma Gold: Q3 Earnings Impacted By Labour Strike

Thesis Gold: The Multi-Billion Dollar Lawyers-Ranch PFS

Why Canada Has So Few Projects That Can Be Built Before 2030 | Dan Wilton – First Mining

Recommended

Northern Superior Shareholders Set To Receive Shares Of ONGold Resources Friday

Goliath Resources Sees Rob McEwen Increase Ownership Interest

Related News

Chinese Biotech Firm LianBio Prices US$325 Million Nasdaq IPO

Biotech company LianBio (Nasdaq: LIAN) started trading on the Nasdaq Global Market today. The Shanghai-based...

Monday, November 1, 2021, 02:07:00 PM

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM

Asia-Focused Biotech SPAC Valuence Merger I Prices US$200 Million IPO

Special purpose acquisition company Valuence Merger Corp. I (Nasdaq: VMCAU) started trading on the Nasdaq...

Tuesday, March 1, 2022, 02:26:00 PM

Birkenstock Files For $8 Billion IPO

Birkenstock, the renowned German footwear company, took a significant step towards going public on Tuesday....

Wednesday, September 13, 2023, 10:36:00 AM

Insurance Firm Ryan Specialty Group Looks To Raise US$1.3 Billion In IPO

Insurance provider Ryan Specialty Group Holdings priced its initial public offering as the company starts...

Thursday, July 22, 2021, 10:27:00 AM